Malaria Vaccines Market Study 2019: Impressively growing Opportunities With Key Companies GlaxoSmithKline, Sanaria, Nobelpharma, Sumaya Biotech

CoherentMarketInsights.com Publish a New Market Research Report On –“ Malaria Vaccines Market 2019 Global Analysis By Key Players – GlaxoSmithKline plc, Sanaria Inc, Nobelpharma Co., Ltd., Sumaya Biotech and GenVec, Inc.”.

The global malaria vaccines market is expected to expand at a CAGR of 102.8% during the forecast period (2016–2024) as there exists a large unrealized market especially in Africa, Asia Pacific, Latin America and Middle East.

Plasmodium Falciparum is the major agent segment of malaria vaccines market, as Plasmodium falciparum infection are induced by the asexual stages of the parasite that develop inside red blood cells, making it one of most severe forms of malaria among various types of parasites causing malaria

According to World Health Organization (WHO) malaria fact sheet and World Bank estimates, over 40% of the global population is at risk of malaria. World Health Organization (WHO), there were around 214 million malaria cases reported in 2015, leading to 438,000 deaths worldwide. Over 70% of these deaths were among children under 5 years of age. Sub-Saharan Africa accounts for the highest share of global malaria burden, with around 89% of malaria cases and 91% of malarial deaths in 2015. Such high impact of this life-threatening disease is influencing governments across various countries, companies, investors, and non-profit organizations to contribute towards curbing spreading of this disease.

Access PDF Template Copy of this Report at:
https://www.coherentmarketinsights.com/insight/request-pdf/37

Since the problem of malaria is burdening many of the emerging and under developed regions such as in Africa and Asia Pacific, various initiatives have been implemented in these regions to drive down high costs of the vaccine in development. For instance, in 2016, GSK announced plans to develop vaccines at a mere profit margin of 5% of the cost of the vaccine. Governments across most regions are actively involved in programs aimed at eliminating malaria. For instance, WHO had mobilized funding for pilot program in first phase between 2017 and 2020 by the global fund to fight against malaria and other disease such as AIDS and tuberculosis prevalent worldwide.

Rampant advancements in the pharmaceutical industry, from oral drugs to parenteral dosage forms is expected boost growth of the malaria vaccines market, globally. Emerging economies are undergoing healthcare reforms, owing to the development of more reliable treatment options, which in turn, is fueling growth of the global market. Increasing number of government and non-government initiatives to eradicate malaria, is also boosting the malaria vaccines market growth. For instance, in 2016, India launched the National Framework for Malaria Elimination (NFME) to eliminate the problem of malaria in the country. This program was based on the Framework by the National Vector Borne Disease Control Program (NVBDCP) of the Ministry of Health and Family Welfare. According to NFME, in 2012, the total economic burden of malaria in India was around US$ 1,940 million, with 75% from lost earnings and 25% from treatment costs borne by households.

According to World Malaria Report 2015, India accounts for around 70% of the total malaria incidence rate in the South-East Asia. In 2014, the incidence in the country was around 0.89 per 1,000 person at risk per year. Around 1.1 million cases were reported, causing 562 deaths in India, in 2014.

People in Africa use insecticide-treated mosquito nets and indoor-insecticide spraying for prevention against malarial vectors. Use of insecticide-treated mosquito nets in Africa increased by 80% during 2010-2015 (WHO). Moreover, a number of mosquito repellent products (patches, creams, coils, mats, liquids, etc.) are marketed globally. Besides, non-profit organizations provide cheap and often free treatment facilities to the malarial affected population in Africa. Also, GSK has pledged to sell the vaccines at a much lower cost forgoing its huge profit margins to support the global malaria eradication programs. Furthermore, with more malarial vaccines under research pipeline, the malaria vaccines market is poised for significant growth in near future.

Get Discount & Customization of this Report Here
https://www.coherentmarketinsights.com/insight/request-discount/37

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com

This release was published on openPR.